Empowered by independence, people with spinal cord injury will enjoy life in the ways that matter to them

Ali Kiboro joined ONWARD as Chief Financial Officer in January 2026 and brings over 25 years of experience across MedTech, global healthcare, diagnostics and industrial organizations. Ali previously served as the Chief Financial Officer at AliveDx where he led financial strategy, capital markets and operational transformation. He raised over $200 million across public and private markets and worked closely with boards, investors, and lenders to drive long term value creation. Prior to AliveDx, Ali served in a variety of senior finance leadership roles at Quest Diagnostics and General Motors. Ali holds an MBA in Finance from The Wharton School of the University of Pennsylvania and a BSc. in Finance, summa cum laude, from Duquesne University.

Sean Sciara is a seasoned global executive with over 25 years of experience in commercial and general management roles in the medical device industry.  He brings deep expertise across global product launches, product management, sales management, and portfolio planning and has successfully launched over 40 products in his career spanning single use devices, active implantable devices, capital equipment, and software.   Prior to joining ONWARD, Sean held senior marketing and sales leadership positions at Guidant, Greatbatch Medical (now part of Integer Holdings), and most recently Boston Scientific where he held several VP level roles including Vice President of Global Marketing for one of the company’s fast growing strategic divisions. Sean holds a Bachelor of Science in Electrical Engineering from Carnegie Mellon University and an MBA from the University of Minnesota.

Shari O’Quinn is an accomplished executive with more than 25 years of leadership experience building and scaling Clinical, Regulatory, Quality, Medical Affairs, and Health Economics functions into strategic drivers of innovation and business growth. She brings deep expertise in Class II and Class III medical devices, global approval pathways, and evidence-based commercialization across all major regions. Shari has held senior roles at W.L. Gore, TriVascular, Endologix, and C.R. Bard. She holds a B.A. from the University of Virginia.

Amori Fraser serves as the Finance Director at ONWARD Medical, leveraging over 18 years of experience in both finance and auditing. Prior to her current role, she worked as a Senior Manager at EY, specializing in financial reporting, regulatory compliance, financial analysis and internal controls serving multi-national listed groups. Amori's experience in auditing and finance enables her to drive efficient financial operations and support the company’s growth initiatives. Amori holds a BComHons degree in Accounting Sciences from the University of Pretoria and is a qualified Chartered Accountant (CA) with the South African Institute of Chartered Accountants (SAICA).

Bob Odell brings to ONWARD decades of leadership experience in the medical device industry. Prior to joining ONWARD, Bob was President and Chief Operating Officer of Cardiac Insight, Inc., a successful startup that introduced disruptive technology to the global marketplace. Prior to Cardiac Insight, he served as COO for Cardiac Science, a publicly traded manufacturer of Class II and Class III devices. Bob has held executive assignments in Operations, Engineering, Marketing, Business Development. Information Technology and General Management with such notables as GE Healthcare, Siemens Medical Solutions, Philips Medical Systems, Medtronic, and Analogic. The foundation for his career is a degree in electrical and computer engineering from Syracuse University.

Sébastien Cros brings extensive experience in global communications across both private and public healthcare companies. Prior to joining ONWARD Medical in May 2025, Sébastien served as Global Head of Corporate Communications at Galderma, the dermatology category leader that went public in 2024. Over the course of 15 years, he held roles of increasing responsibility at Galderma and Nestlé’s skin health division, where he successively led global teams in media relations, public affairs, financial communications, transformation and employee engagement, issues and crisis management, global congresses and events, and digital. Earlier in his career, he served as digital marketing and economic intelligence project lead at Servier International. Sébastien holds a Doctor of Pharmacy (PharmD) degree from the University of Montpellier, France, and an LLM in Intellectual Property.

Lorenzo Fanti is a dual-qualified US and English attorney with nearly 15 years of experience specializing in pharmaceuticals and medtech. Prior to joining ONWARD Medical, Lorenzo served as worldwide Legal Head, Ophthalmology ad interim at Novartis Pharmaceuticals, and, prior to that, he was Country Legal Head for Chile ad interim for the Novartis group of companies. He has held various roles with increasing responsibility at Novartis, including in the Neuroscience franchise, where he contributed to the launch of innovative migraine treatments. Early in his career, he was a Trademark Paralegal with Sandoz, and he trained with Allen & Overy LLP in London. He holds an LL.B. from the University of Wales.